Novel adjuvant
AssigneesNippon Zenyaku Kogyo Co., Ltd., Osaka University
InventorsToshihiro Tsukui, Ken Ishii, Shizuo Akira, Cevayir Coban
Life of this patent
Estimating the term…
Abstract
The present invention provides a vaccine adjuvant composition which is used in combination with an allergen vaccine, infection vaccine or tumor vaccine. The present invention specifically provides a vaccine adjuvant composition comprising hemozoin or β-hematin and being used in combination with an allergen vaccine, infection vaccine or tumor vaccine, and a vaccine composition comprising the vaccine adjuvant composition and an allergen vaccine, infection vaccine or tumor vaccine
Claims9
1-24. (canceled)
A method of preventing or treating allergic disease, infectious disease or tumor, which comprises administering a vaccine composition comprising a vaccine adjuvant composition comprising hemozoin or β-hematin in combination with a vaccine selected from the group consisting of an allergen vaccine, an infection vaccine and a tumor vaccine to a subject.
A method of activating dendritic cell, which comprises contacting the dendritic cell with hemozoin or β-hematin.
A method of preventing or treating allergic disease, infectious disease or tumor, which comprises administering a vaccine composition comprising a vaccine adjuvant composition comprising hemozoin or β-hematin and Alum adjuvant, and vaccine to a subject.
Dependencies are inferred from the claim text.